Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Phibro Animal Health Corporation(PAHC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PAHC
11/06/2026: PAHC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Phibro Animal Health Corporation is a mid-cap manufacturer focused on the animal health, mineral nutrition, and specialty chemical markets. The company maintains a leading position in the livestock feed additive space, providing essential products for producers globally. Its primary growth opportunity lies in expanding its vaccine and biologicals portfolio to improve margins and diversify its revenue base. Investors should be aware of risks including reliance on livestock production cycles, evolving antibiotic regulations, and stiff competition from larger incumbents. This stock may suit value-oriented investors who value steady earnings and a reliable dividend, though they should closely monitor regulatory changes and animal disease trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is steady rather than explosive, tied closely to global livestock population trends. |
| Momentum investor | Weak fit | The stock tends to trade based on long-term fundamentals rather than short-term price momentum. |
| Value investor | Strong fit | The company often trades at valuations that may interest investors seeking stable earnings in the agricultural space. |
| Dividend investor | Mixed fit | It provides a reliable dividend but is not primarily a high-yield income vehicle. |
| Low-risk investor | Medium | While established, the stock carries industry-specific risks related to animal health regulations and disease cycles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can be sensitive to quarterly variations in livestock feed prices and animal health demand. |
| Valuation risk | Low | The company typically trades at reasonable multiples compared to high-growth biotech. |
| Competition risk (Livestock Health) | Medium / high | Major players like Zoetis have greater resources for R&D and global distribution. |
| Business quality | Medium | The company has a solid, established franchise but lower margins than pure-play animal pharma. |
| Dividend income | Medium | Dividends are stable but provide limited total return growth. |
| Execution risk | Medium | Successfully transitioning the product mix toward vaccines is critical for long-term relevance. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 73.42% | Avg. Invested days 47 | Today’s Advisory WEAK BUY |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.34B USD | Price to earnings Ratio 13.13 | 1Y Target Price 47 |
Price to earnings Ratio 13.13 | 1Y Target Price 47 | ||
Volume (30-day avg) 224.5K shares | Beta 0.4 | 52 Weeks Range 28.04 - 59.64 | Updated Date 11/08/2026 |
52 Weeks Range 28.04 - 59.64 | Updated Date 11/08/2026 | ||
Dividends yield (FY) 1.36% | Basic EPS (TTM) 2.51 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Animal Health | Medicated additives and vaccines for poultry, swine, and cattle. | This is the primary revenue engine focused on food production. |
| Mineral Nutrition | Trace minerals and nutritional additives. | This provides a steady, essential ingredient revenue stream. |
| Performance Products | Specialty chemicals and ingredients for ethanol production. | This is a smaller, cyclical segment tied to industrial demand. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-04 | When After Market | Estimate 0.79 | Actual 0.79 |
Profitability
Profit Margin 6.67% | Operating Margin (TTM) 13.02% |
Management Effectiveness
Return on Assets (TTM) 8.44% | Return on Equity (TTM) 28.17% |
Valuation
Trailing PE 13.13 | Forward PE 13.83 | Enterprise Value 2.04B | Price to Sales(TTM) 0.87 |
Enterprise Value 2.04B | Price to Sales(TTM) 0.87 | ||
Enterprise Value to Revenue 1.33 | Enterprise Value to EBITDA 8.67 | Shares Outstanding 21.11M | Shares Floating 20.91M |
Shares Outstanding 21.11M | Shares Floating 20.91M | ||
Percent Insiders 0.88 | Percent Institutions 102.59 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.